Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 4
Submit an article Journal homepage
236
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia

Jefferson Antonio Buendíaa Research Group in Pharmacology and Toxicology ”Infarto”. Department of Pharmacology and Toxicology. University of Antioquia, Universidad de Antioquia, Medellín, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2404-6612
ORCID Icon &
Diana Guerrero Patiñob Deparment of Child Health, Hospital Infantil Concejo de Medellín, Colombia
Pages 575-580 | Received 07 Aug 2021, Accepted 23 Nov 2021, Published online: 03 Dec 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Paola Rogliani & Mario Cazzola. (2023) Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval. Expert Opinion on Investigational Drugs 32:6, pages 525-536.
Read now
Abraham Ali, Elizabeth García, Carlos A Torres-Duque, Diana Rey, Laura Botero, Stid Saenz, Maria Paula Avila, Elizabeth Mazo & Sergio Londoño. Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab and benralizumab added to the standard of care in adults with severe asthma in Colombia. Expert Review of Pharmacoeconomics & Outcomes Research 0:0.
Read now

Articles from other publishers (4)

Tomas Abbott, Carlos Balmaceda, Paula Zamorano, Andres Giglio & Manuel Espinoza. (2023) Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile. Value in Health Regional Issues 35, pages 69-77.
Crossref
Jefferson Antonio Buendía, Ricardo Hernández-Sarmiento & Jorge Enrique Rojas Medina. (2023) Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country. Value in Health Regional Issues 35, pages 1-7.
Crossref
Jefferson A. Buendía, John E. Feliciano‐Alfonso & Ivan D. Florez. (2022) Systematic review and cost‐utility of high flow nasal cannula versus continuous positive airway pressure in children with acute severe or moderate bronchiolitis in Colombia. Pediatric Pulmonology 57:12, pages 3111-3118.
Crossref
Jefferson A. Buendía & Diana G. Patiño. (2022) Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis. Pediatric Pulmonology 57:10, pages 2313-2319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.